Trends in Nanomedicine (TechVision)

Nano-based science paving the precision medicine era

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The continued development of new treatments associated with the demographic trends and public health considerations is remarkable. Nanotechnology has been identified as one most relevant key enabling technologies of the last ten years, significantly impacting on many different biomedical developments in a broad spectrum of applications therapeutics, diagnostics, theranostics, medical imaging, regenerative medicine, life sciences research and biosciences, among many others. In fact, nanomedicine is present in all therapeutic areas, exhibiting a perceptible and extensive impact in the treatment and diagnosis of some most concerned diseases.

Innovation in nanomedicine fields has played a major role in the improvement of both length and quality of life during the present decade, appreciably advocated to reduce the disease burden for individuals and the society through completely new or improved diagnostic and therapeutic methods. Groundbreaking advances in the scientific understanding of the underlying mechanisms of disease are paving the way for nanomedicine on precision medicine topics.

Frost & Sullivan (www.frost.com/techvision) identified an unprecedented behavior in terms of innovation in nanomedicine fields, with notable acceptance in diagnostics, therapeutics, companion diagnostics, regenerative medicine, and many other applications that are undoubtedly linked to the concept of precision medicine. Nanomedicine enables personalized medicine approaches in many ways. As an instance, nano-based diagnostic tests or nano-imaging diagnosis may help to the stratification of patients and thereby to guarantee a most personalized, patient-centered therapy. In addition, clinical protocols become simpler, more efficient and less costly.

Table of Contents

Executive SummaryResearch ScopeResearch Scope (continued)Research MethodologyKey FindingsTechnology Snapshot and TrendsIndustry Value Chain and Business ModelCore Technology ApplicationsTechnology EvolutionCore Growth OpportunitiesTechnology Synergy and NanobiotechnologyTechnology RoadmapIndustry Drivers and RestraintsIndustry Technical and Business ChallengesMarket Drivers and RestraintsTechnology Drivers and RestraintsPorter’s Five Forces AnalysisIndustry Models and Applications TargetedNanomedicine Innovation ModelNanomedicine Innovation Model (continued)Nanomedicine Innovation Model (continued)Nanomedicines Application Focus Nanomedicines Therapeutics FocusNanomedicines Diagnostics FocusNanomedicines Regenerative Medicine FocusProduct Development and Market PotentialNanomedicine Multiple SegmentationNanomedicines Principal Industry FactsNanomedicines Principal Industry Facts (continued)Nanomedicine Development PipelineNanomedicine Products by Developmental PhaseGlobal Nanomedicine MarketGlobal Nanomedicine Market (continued)Global Nanomedicine Market (continued)Product PipelineProduct Pipeline (continued)Product Pipeline (continued)Product Pipeline (continued)Product Pipeline (continued)Product Pipeline (continued)Key Stakeholder Analysis Nanomedicine Marketed ProductsNanomedicine Marketed Products (continued)Nanomedicine Marketed Products (continued)Key Companies in North AmericaKey Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in North America (continued)Key Companies in EuropeKey Companies in Europe (continued)Key Companies in Europe (continued)Key Companies in Europe (continued)Key Companies in Europe (continued)Key Companies in Europe (continued)Key Companies in Europe (continued)Key Companies in Asia PacificKey Companies in Asia Pacific (continued)Intellectual PropertyIntellectual Property (continued)Intellectual Property (continued)Technology Benchmarking Multicriteria Approach for Benchmarking Multicriteria Approach for Benchmarking (continued)Multicriteria Approach for Benchmarking (continued)Multicriteria Approach for Benchmarking (continued)Multicriteria Approach for Benchmarking (continued)Multicriteria Approach for Benchmarking (continued)Multicriteria Approach for Benchmarking (continued)Multicriteria Approach for Benchmarking (continued)Multicriteria Approach for Benchmarking (continued)Final RemarksLegal DisclaimerAppendixKey ContactsKey Contacts (continued)Key Contacts (continued)Key Contacts (continued)Key Contacts (continued)Key Contacts (continued)Key Contacts (continued)Intellectual Property SourcesKey PatentsKey Patents (continued)Key Patents (continued)The Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Related Research

Release Date : 15-Sep-17

Region : Global

Release Date : 14-Sep-17

Region : Global

Release Date : 11-Sep-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.